Advertisement
Research Article| Volume 54, ISSUE 8, P833-839, October 15, 2003

S-adenosyl-l-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects

  • Marisa M. Silveri
    Correspondence
    Address reprint requests to Marisa M. Silveri, Ph.D., Brain Imaging Center, McLean Hospital, Belmont, MA 02478, USA.
    Affiliations
    Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA (MMS, ALS, BMC, PFR)

    Brain Imaging Center (MMS, AMP, RAV, ALS, BMC, PFR), McLean Hospital, Belmont, Massachusetts, USA
    Search for articles by this author
  • Aimee M. Parow
    Affiliations
    Brain Imaging Center (MMS, AMP, RAV, ALS, BMC, PFR), McLean Hospital, Belmont, Massachusetts, USA
    Search for articles by this author
  • Rosemond A. Villafuerte
    Affiliations
    Brain Imaging Center (MMS, AMP, RAV, ALS, BMC, PFR), McLean Hospital, Belmont, Massachusetts, USA
    Search for articles by this author
  • Karen E. Damico
    Affiliations
    Psychopharmacology Research Laboratory (KED, JG, ALS, BMC), McLean Hospital, Belmont, Massachusetts, USA
    Search for articles by this author
  • Jessica Goren
    Affiliations
    Psychopharmacology Research Laboratory (KED, JG, ALS, BMC), McLean Hospital, Belmont, Massachusetts, USA

    Pharmacy Practice, Northeastern University, Boston, Massachusetts, USA (JG)
    Search for articles by this author
  • Andrew L. Stoll
    Affiliations
    Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA (MMS, ALS, BMC, PFR)

    Brain Imaging Center (MMS, AMP, RAV, ALS, BMC, PFR), McLean Hospital, Belmont, Massachusetts, USA

    Psychopharmacology Research Laboratory (KED, JG, ALS, BMC), McLean Hospital, Belmont, Massachusetts, USA
    Search for articles by this author
  • Bruce M. Cohen
    Affiliations
    Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA (MMS, ALS, BMC, PFR)

    Brain Imaging Center (MMS, AMP, RAV, ALS, BMC, PFR), McLean Hospital, Belmont, Massachusetts, USA

    Psychopharmacology Research Laboratory (KED, JG, ALS, BMC), McLean Hospital, Belmont, Massachusetts, USA
    Search for articles by this author
  • Perry F. Renshaw
    Affiliations
    Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA (MMS, ALS, BMC, PFR)

    Brain Imaging Center (MMS, AMP, RAV, ALS, BMC, PFR), McLean Hospital, Belmont, Massachusetts, USA
    Search for articles by this author

      Abstract

      Background

      S-adenosyl-L-methionine is an effective treatment for clinical depression, although the mechanism underlying this effect is unclear. Presently, in vivo phosphorus 31 magnetic resonance spectroscopy and brain transverse relaxometry were employed to test if S-adenosyl-L-methionine supplementation alters brain bioenergetics and/or transverse relaxation time in a nondepressed cohort. If these magnetic resonance techniques are sensitive to S-adenosyl-L-methionine induced alterations in neurochemical processes, these methods may be used in cases of clinical depression to elucidate the mechanism underlying the antidepressant effect of S-adenosyl-L-methionine.

      Methods

      Twelve subjects self-administered 1600 mg of oral S-adenosyl-L-methionine daily. Phosphorus 31 spectra and transverse relaxation time were acquired at baseline and after treatment using a 1.5 Tesla scanner.

      Results

      Mole percent concentrations of phosphocreatine were significantly higher after treatment, whereas mole percent β nucleoside triphosphate levels, predominantly adenosine triphosphate in brain, were significantly lower after treatment. In addition, a surprising gender difference in transverse relaxation time emerged after supplementation, with women exhibiting significantly lower transverse relaxation time than men.

      Conclusions

      The alterations in phosphocreatine and β nucleoside triphosphate are consistent with the report that S-adenosyl-L-methionine is involved in the production of creatine, which in turn is phosphorylated to phosphocreatine using adenosine triphosphate. These findings suggest that S-adenosyl-L-methionine alters parameters associated with cerebral bioenergetic status and that some effects of S-adenosyl-L-methionine (transverse relaxation time) occur in a gender-specific manner.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Alarcon R.D.
        • Tolbert L.C.
        • Monti J.A.
        • Morere D.A.
        • Walter-Ryan W.G.
        • Kemp B.
        • et al.
        One-carbon metabolism disturbances in affective disorders. A preliminary report.
        J Affect Disord. 1985; 9: 297-301
      1. Anderson CM, Lowen SB, Renshaw PF, Kaufman MJ, Teicher MH (2000): Non-invasive T2-relaxation time measures correlate with gadolinium-based cerebral blood volume estimates in the putamen and cerebellar vermis of young adults [abstract]. Abstr Soc Neurosci 26:1730

        • Baldessarini R.J.
        Neuropharmacology of S-adenosyl-L-methionine.
        Am J Med. 1987; 83: 95-103
        • Bell K.M.
        • Potkin S.G.
        • Carreon D.
        • Plon L.
        S-adenosylmethionine blood levels in major depression.
        Acta Neurol Scand Suppl. 1994; 154: 15-18
        • Bessman S.P.
        • Carpenter C.L.
        The creatine-creatine phosphate energy shuttle.
        Annu Rev Biochem. 1985; 54: 831-862
        • Bottiglieri T.
        • Godfrey P.
        • Flynn T.
        • Carney M.W.
        • Toone B.K.
        • Reynolds E.H.
        Cerebrospinal fluid S-adenosylmethionine in depression and dementia.
        J Neurol Neurosurg Psychiatry. 1990; 53: 1096-1098
        • Bottiglieri T.
        • Hyland K.
        • Reynolds E.H.
        The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.
        Drugs. 1994; 48: 137-152
        • Braissant O.
        • Henry H.
        • Loup M.
        • Eilers B.
        • Bachmann C.
        Endogenous synthesis and transport of creatine in the rat brain.
        Brain Res Mol Brain Res. 2001; 86: 193-201
        • Bressa G.M.
        S-adenosyl-l-methionine (SAMe) as antidepressant.
        Acta Neurol Scand Suppl. 1994; 154: 7-14
        • Buchsbaum M.S.
        • Wu J.
        • DeLisi L.E.
        • Holcomb H.
        • Kessler R.
        • Johnson J.
        • et al.
        Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.
        J Affect Disord. 1986; 10: 137-152
        • Christensen J.D.
        • Kaufman M.J.
        • Levin J.M.
        • Mendelson J.H.
        • Holman B.L.
        • Cohen B.M.
        • et al.
        Abnormal cerebral metabolism in polydrug abusers during early withdrawal.
        Magn Reson Med. 1996; 35: 658-663
        • Drevets W.C.
        Functional neuroimaging studies of depression.
        Annu Rev Med. 1998; 49: 341-361
        • Dunn R.T.
        • Kimbrell T.A.
        • Ketter T.A.
        • Frye M.A.
        • Willis M.W.
        • Luckenbaugh D.A.
        • et al.
        Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression.
        Biol Psychiatry. 2002; 51: 387-399
        • Estilaei M.R.
        • Matson G.B.
        • Payne G.S.
        • Leach M.O.
        • Fein G.
        • Meyerhoff D.J.
        Effects of chronic alcohol consumption on the broad phospholipid signal in human brain.
        Alcohol Clin Exp Res. 2001; 25: 89-97
        • Ganesan V.
        • Johnson A.
        • Connelly A.
        • Eckhardt S.
        • Surtees R.A.
        Guanidinoacetate methyltransferase deficiency.
        Pediatr Neurol. 1997; 17: 155-157
        • Grubb Jr, R.L.
        • Raichle M.E.
        • Eichling J.O.
        • Ter-Pogossian M.M.
        The effects of changes in PaCO2 on cerebral blood volume, blood flow, and vascular mean transit time.
        Stroke. 1974; 5: 630-639
      2. Haacke EM, Brown RW, Thompson MR, Venkatesan R (1999): Spin density, T1 and T2 quantification methods in MR imaging. In: Magnetic Resonance Imaging Physical Principles and Sequence Design. New York: John Wiley & Sons, Inc., 637–667

        • Hamilton M.
        A rating scale for depression.
        J Neurol Neurosurg Psychiatry. 1960; 28: 56-62
        • Hoffman J.
        A rapid liquid chromatographic determination of S-adenosylhomocysteine in subgram amounts of tissue.
        Anal Biochem. 1975; 68: 522-530
        • Holtzman D.
        • Mulkern R.
        • Meyers R.
        • Cook C.
        • Allred E.
        • Khait I.
        • et al.
        In vivo phosphocreatine and ATP in piglet cerebral gray and white matter during seizures.
        Brain Res. 1998; 783: 19-27
        • Kagan B.L.
        • Sultzer D.L.
        • Rosenlicht N.
        • Gerner R.H.
        Oral S-adenosylmethionine in depression.
        Am J Psychiatry. 1990; 147: 591-595
        • Kaufman M.J.
        • Pollack M.H.
        • Villafuerte R.A.
        • Kukes T.J.
        • Rose S.L.
        • Mendelson J.H.
        • et al.
        Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance.
        Psychiatry Res. 1999; 90: 143-152
        • Kimbrell T.A.
        • Ketter T.A.
        • George M.S.
        • Little J.T.
        • Benson B.E.
        • Willis M.W.
        • et al.
        Regional cerebral glucose utilization in patients with a range of severities of unipolar depression.
        Biol Psychiatry. 2002; 51: 237-252
        • Lee H.
        • Ogawa H.
        • Fujioka M.
        • Gerton G.L.
        Guanidinoacetate methyltransferase in the mouse.
        Biol Reprod. 1994; 50: 152-162
        • Lim K.O.
        • Pauly J.
        • Webb P.
        • Hurd R.
        • Macovski A.
        Short TE phosphorus spectroscopy using a spin-echo pulse.
        Magn Reson Med. 1994; 32: 98-103
        • Lu S.C.
        S-Adenosylmethionine.
        Int J Biochem Cell Biol. 2000; 32: 391-395
        • Luyten P.R.
        • Bruntink G.
        • Sloff F.M.
        • Vermeulen J.W.
        • van der Heijden J.I.
        • den Hollander J.A.
        • et al.
        Broadband proton decoupling in human 31P NMR spectroscopy.
        NMR Biomed. 1989; 1: 177-183
      3. Lyoo IK, Hirashima F, Parow AM, Sung SM, Cohen BM, Renshaw PF (2002): Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate [abstract]. Biol Psychiatry 51:141

        • Mayberg H.S.
        Frontal lobe dysfunction in secondary depression.
        J Neuropsychiatry Clin Neurosci. 1994; 6: 428-442
        • Moore C.M.
        • Christensen J.D.
        • Lafer B.
        • Fava M.
        • Renshaw P.F.
        Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects.
        Am J Psychiatry. 1997; 154: 116-118
        • Murphy-Boesch J.
        • Stoyanova R.
        • Srinivasan R.
        • Willard T.
        • Vigneron D.
        • Nelson S.
        • et al.
        Proton-decoupled 31P chemical shift imaging of the human brain in normal volunteers.
        NMR Biomed. 1993; 6: 173-180
        • Petroff O.A.
        • Prichard J.W.
        • Behar K.L.
        • Alger J.R.
        • den Hollander J.A.
        • Shulman R.G.
        Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy.
        Neurology. 1985; 35: 781-788
        • Renshaw P.F.
        • Parow A.M.
        • Hirashima F.
        • Ke Y.
        • Moore C.M.
        • Frederick B.D.
        • et al.
        Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression.
        Am J Psychiatry. 2001; 158: 2048-2055
        • Rosenbaum J.F.
        • Fava M.
        • Falk W.E.
        • Pollack M.H.
        • Cohen L.S.
        • Cohen B.M.
        • et al.
        The antidepressant potential of oral S-adenosyl-l-methionine.
        Acta Psychiatr Scand. 1990; 81: 432-436
        • Sherer M.A.
        • Cantoni G.L.
        • Golden R.N.
        • Rudorfer M.V.
        • Potter W.Z.
        Effects of S-adenosyl-methionine on plasma norepinephrine, blood pressure, and heart rate in healthy volunteers.
        Psychiatry Res. 1986; 17: 111-118
      4. Silveri MM, Pollack MH, Diaz CI, Nassar LE, Mendelson JH, Yurgelun-Todd DA (2002): Cerebral bioenergetic changes at onset of methadone maintenance treatment in heroin-dependent polydrug abusers [abstract]. Drug Alcohol Depend 66:S164

        • Spitzer R.L.
        • Williams J.B.
        • Gibbon M.
        • First M.B.
        The Structured Clinical Interview for DSM-III-R (SCID). I.
        Arch Gen Psychiatry. 1992; 49: 624-629
        • Stockler S.
        • Hanefeld F.
        • Frahm J.
        Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism.
        Lancet. 1996; 348: 789-790
        • Stramentinoli G.
        Pharmacologic aspects of S-adenosylmethionine. Pharmacokinetics and pharmacodynamics.
        Am J Med. 1987; 83: 35-42
        • Teicher M.H.
        • Anderson C.M.
        • Polcari A.
        • Glod C.A.
        • Maas L.C.
        • Renshaw P.F.
        Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry.
        Nat Med. 2000; 6: 470-473
        • van Zijl P.C.
        • Eleff S.M.
        • Ulatowski J.A.
        • Oja J.M.
        • Ulug A.M.
        • Traystman R.J.
        • et al.
        Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging.
        Nat Med. 1998; 4: 159-167
        • Volz H.P.
        • Rzanny R.
        • Riehemann S.
        • May S.
        • Hegewald H.
        • Preussler B.
        • et al.
        31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients.
        Eur Arch Psychiatry Clin Neurosci. 1998; 248: 289-295
        • Wise C.
        • Fullerton F.
        Analytical procedure for determination of s-adenosylmethionine, s-adenosylhomocysteine, and s-adenosylethionine in same isocratic HPLC run, with a procedure for preparation and analysis of the analog s-adenosylhomocysteine sulfoxide.
        J Liq Chromatogr. 1995; 18: 2005-2017
        • Wise C.K.
        • Cooney C.A.
        • Ali S.F.
        • Poirier L.A.
        Measuring S-adenosylmethionine in whole blood, red blood cells and cultured cells using a fast preparation method and high-performance liquid chromatography.
        J Chromatogr B Biomed Sci Appl. 1997; 696: 145-152
        • Wyss M.
        • Kaddurah-Daouk R.
        Creatine and creatinine metabolism.
        Physiol Rev. 2000; 80: 1107-1213
        • Young R.C.
        • Biggs J.T.
        • Ziegler V.E.
        • Meyer D.A.
        A rating scale for mania.
        Br J Psychiatry. 1978; 133: 429-435